Novocure Ltd Stock Analysis & AI Score
Novocure Ltd (NVCR) has an ST Score of 52.2 (B-), driven by its Momentum (A-) and held back by its Financial Strength (D+). Analysts rate it Buy with a $26.00 price target (+60.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Novocure Ltd (NVCR) has an ST Score of 52.2 (B-), driven by its Momentum (A-) and held back by its Financial Strength (D+). Analysts rate it Buy with a $26.00 price target (+60.5% upside).
- Strongest
- MomentumA-
- Weakest
- Financial StrengthD+
All factor grades
- MomentumA-
- ForecastB+
- ValuationB
- ProfitabilityC-
- GrowthC-
- Financial StrengthD+
- Piotroski5/9
Contact
NVCR stock: frequently asked questions
What is NVCR's ST Score?
Novocure Ltd (NVCR) has an ST Score of 52.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NVCR a buy, hold, or sell?
Analysts rate NVCR a Buy, with a price target of $26.00 (+60.5% vs the current price). Our ST Score grades it B- (52.2/100). The ST Score is a data-driven signal, not a recommendation.
What are NVCR's factor grades?
Valuation B, Profitability C-, Financial Strength D+, Momentum A-, Growth C-, Forecast B+.
What is NVCR's valuation grade?
Novocure Ltd (NVCR) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NVCR's growth grade?
Novocure Ltd (NVCR) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NVCR's profitability grade?
Novocure Ltd (NVCR) earns a profitability grade of C-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NVCR's financial strength grade?
Novocure Ltd (NVCR) earns a financial strength grade of D+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NVCR?
The average analyst price target for Novocure Ltd (NVCR) is $26.00 from 15 analysts, which is +60.5% versus the recent price of $16.20.
What is NVCR's Piotroski score?
Novocure Ltd (NVCR) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.